Ocular outcomes in 4-year old prematurely born children

Przeglad Lekarski
|April 26, 2018
PubMed

Insights

Laser coagulation for retinopathy of prematurity in very low birth weight (VLBW) children impacts visual outcomes. While effective, it

Area of Science:

  • Ophthalmology
  • Neonatology
  • Developmental Pediatrics

Background:

  • Very low birth weight (VLBW) infants are at high risk for retinopathy of prematurity (ROP).
  • ROP can lead to significant visual impairment and structural eye abnormalities.
  • Early assessment of ophthalmic outcomes in VLBW children is crucial for timely intervention.

Purpose of the Study:

  • To evaluate functional and structural ophthalmic outcomes in 4-year-old very low birth weight children.
  • To compare outcomes between VLBW children with and without retinopathy of prematurity, and those treated with laser coagulation.
  • To identify factors influencing visual development in this high-risk population.

Main Methods:

  • Study included 82 VLBW children categorized into three groups: no ROP, ROP without laser treatment, and ROP treated with laser coagulation.
  • Comprehensive ophthalmic examinations included visual acuity, visual evoked potentials (VEP), stereopsis, color vision, cycloplegic refraction, and structural assessments.
  • Developmental Test of Visual Perception (DTVP) was also administered.

Main Results:

  • The majority of VLBW children (68.3%) achieved very good visual acuity.
  • Refractive errors were common, with 28.1% myopic and 59.8% having astigmatism > 1D.
  • Children treated for ROP with laser coagulation showed significantly more abnormal VEP results (54%) and lower stereopsis (46.9%) compared to other groups (p<0.05).
  • Lower DTVP scores were observed in the laser-treated ROP group.
  • Structural abnormalities included eyelid naevus, eyeball atrophy, aphakia, optic disc drusen, pale optic discs, and retinal detachment.

Conclusions:

  • Laser coagulation for retinopathy of prematurity is an effective treatment for active stages of ROP.
  • While effective, laser treatment for ROP can impact long-term functional visual outcomes in VLBW children.
  • VLBW children treated for ROP with laser coagulation require continued monitoring for visual development and potential complications.
Abstract

Related Concept Videos

The Born-Haber Cycle02:44

The Born-Haber Cycle

Lattice Energy 
25.5K
Predicting Reaction Outcomes02:24

Predicting Reaction Outcomes

Kinetics describes the rate and path by which a reaction occurs. In contrast, thermodynamics deals with state functions and describes the properties, behavior, and components of a system. It is not concerned with the path taken by the process and cannot address the rate at which a reaction occurs. Although it does provide information about what can happen during a reaction process, it does not describe the detailed steps of what appears on an atomic or a molecular level. On the other hand,...
11.0K
Outcomes of Glycolysis01:13

Outcomes of Glycolysis

Nearly all the energy used by cells comes from the bonds that make up complex organic compounds. These organic compounds are broken down into simpler molecules, such as glucose. As a result, cells extract energy from glucose over many chemical reactions—a process called cellular respiration.
Cellular respiration can occur aerobically (with oxygen) or anaerobically (without oxygen). In the presence of oxygen, cellular respiration starts with glycolysis and continues with pyruvate...
107.7K
Guidelines for Writing Outcome01:11

Guidelines for Writing Outcome

When developing expected outcomes for a patient care plan, the nurse should adhere to the following recommendations:
Patient outcomes reflect the patient's response to the goal rather than what the nurse aims to achieve. Terminology should be observable and measurable to avoid the reader's interpretation. The desired outcome should be realistic and achievable in the designated care timeframe. Expected outcomes should align with adjunctive therapies. The outcome should enhance care...
4.0K
Drug Dosing: Infants and Children01:29

Drug Dosing: Infants and Children

Pediatric patient dosages diverge from adults due to disparities in body surface area, total body water, and extracellular fluid per kilogram of body weight. The dosing regimen considers the variations in pharmacokinetics and pharmacology across distinct age groups, encompassing preterm newborns, infants, young children, older children, and adolescents. Calculation of pediatric patient doses is predicated on determining body surface area, which exhibits a superior correlation with the child's...
324
Dipeptidyl Peptidase 4 Inhibitors01:23

Dipeptidyl Peptidase 4 Inhibitors

Dipeptidyl peptidase 4 (DPP-4) is a serine protease widely distributed in the body. It's involved in the inactivation of GLP-1 and GIP hormones, which are crucial for insulin regulation. DPP-4 inhibitors, such as sitagliptin (Januvia), saxagliptin (Onglyza), linagliptin (Tradjenta), alogliptin (Nesina), and vildagliptin (Galvus), help increase the proportion of active GLP-1, enhancing insulin secretion. These inhibitors work by competitively binding to DPP-4. This binding causes a...
693